Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.
Press releases published on September 2, 2025
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
BASKING RIDGE, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to …
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today …
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PRINCETON, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
GlobeNewswire
·
September 2, 2025
VAIL, Colorado / BASALT, Colorado, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD) has awarded a $962,977 contract to Steadman Philippon Research Institute (SPRI) to launch a year-long clinical study focused on improving therapies …
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
GlobeNewswire
·
September 2, 2025
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, …
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
GlobeNewswire
·
September 2, 2025
Toronto, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TORONTO — Aug. 28, 2025 — Vielight, the pioneers of brain photobiomodulation (PBM) neurotechnology, is rapidly emerging as a game-changer for elite athletes. NFL and NCAA football players, Olympic …
Avaap Introduces New Program to Make it Easier for Emerging Higher Education and Government Organizations to Deploy Workday
GlobeNewswire
·
September 2, 2025
COLUMBUS, Ohio, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Avaap, a recognized leader in digital transformation for higher education, government, and nonprofit sectors, today announced the launch of Avaap One, an innovative deployment program designed to make it …
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical …
Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky …
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
GlobeNewswire
·
September 2, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic …
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
GlobeNewswire
·
September 2, 2025
Julie Clark, M.D., promoted to Chief Medical Officer Liansheng Zhu, Ph.D., joined as SVP, Biometrics and Data Quality 4FRONT-1 Phase 3 trial enrollment continues to exceed expectations, with enrollment completion now expected in Q1 2026 Addition of …
electroCore to Participate at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
ROCKAWAY, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the H.C. Wainwright 27th Annual Global Investment …
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
GlobeNewswire
·
September 2, 2025
PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, …
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis (EoE), Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI
GlobeNewswire
·
September 2, 2025
At 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with EP-104GI All Cohorts followed to 9 months have maintained clinically meaningful improvements in tissue health as measured by EoE …
Lakeside Software Accelerates Growth and Innovation with Three Executive Appointments
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lakeside Software, the industry-leading digital employee experience company, today announced the appointment of three seasoned executives to its leadership team: Oli Giordimaina as Chief Product Officer, Brian …
vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund
GlobeNewswire
·
September 2, 2025
Proceeds to fund ongoing CATT1 Phase 3 trial and continued development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes Topline data from CATT1 Phase 3 trial on …
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) …